CN1768031A - 作为治疗剂的异羟肟酸酯 - Google Patents

作为治疗剂的异羟肟酸酯 Download PDF

Info

Publication number: CN1768031A
Authority: CN; China
Prior art keywords: hydroxyl; benzamide; oxyethyl group; group; base carbonylamino
Prior art date: 2003-04-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN 200480009225

Other languages

English (en)

Chinese (zh)

Inventor

埃里克·J·弗纳

马丁·森齐克

奇特拉·鲍什考兰

约瑟夫·J·巴格杰

詹姆士·鲁宾逊

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Axys Pharmaceuticals Inc

Original Assignee

Axys Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-07

Filing date

2004-04-06

Publication date

2006-05-03

2004-04-06 Application filed by Axys Pharmaceuticals Inc filed Critical Axys Pharmaceuticals Inc

2004-04-06 Priority to CN201110221257.6A priority Critical patent/CN102391222B/zh

2006-05-03 Publication of CN1768031A publication Critical patent/CN1768031A/zh

Status Pending legal-status Critical Current

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyridine Compounds (AREA)

CN 200480009225 2003-04-07 2004-04-06 作为治疗剂的异羟肟酸酯 Pending CN1768031A (zh)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CN201110221257.6A CN102391222B (zh)	2003-04-07	2004-04-06	作为治疗剂的异羟肟酸酯

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US46128603P	2003-04-07	2003-04-07
US60/461,286		2003-04-07
US60/464,448		2003-04-21

Related Child Applications (2)

Application Number	Title	Priority Date	Filing Date
CN201110221257.6A Division CN102391222B (zh)	2003-04-07	2004-04-06	作为治疗剂的异羟肟酸酯
CN2011102212773A Division CN102304110A (zh)	2003-04-07	2004-04-06	作为治疗剂的异羟肟酸酯

Publications (1)

Publication Number	Publication Date
CN1768031A true CN1768031A (zh)	2006-05-03

Family

ID=36743306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN 200480009225 Pending CN1768031A (zh)	2003-04-07	2004-04-06	作为治疗剂的异羟肟酸酯

Country Status (3)

Country	Link
CN (1)	CN1768031A (uk)
UA (1)	UA82876C2 (uk)
ZA (1)	ZA200507751B (uk)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102548975A (zh) *	2009-07-07	2012-07-04	安瑟生物科技私人有限公司	组蛋白去乙酰化酶抑制剂
CN102775368A (zh) *	2011-05-10	2012-11-14	中国科学院上海药物研究所	一类噻唑类化合物及其制备方法和用途
CN101674820B (zh) *	2006-12-26	2013-09-25	药品循环公司	在联合治疗中应用组蛋白脱乙酰酶抑制剂并监测生物标志物的方法
CN103906732A (zh) *	2011-10-28	2014-07-02	株式会社钟根堂	用作hdac抑制剂的异羟肟酸酯衍生物以及包含所述衍生物的药物组合物
CN103917231A (zh) *	2011-09-13	2014-07-09	药品循环公司	组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
CN119528810A (zh) *	2024-12-09	2025-02-28	山东第一医科大学(山东省医学科学院)	喹啉类化合物及其应用

2004
- 2004-04-06 CN CN 200480009225 patent/CN1768031A/zh active Pending
- 2004-04-06 ZA ZA200507751A patent/ZA200507751B/en unknown
- 2004-06-04 UA UAA200510426A patent/UA82876C2/uk unknown

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101674820B (zh) *	2006-12-26	2013-09-25	药品循环公司	在联合治疗中应用组蛋白脱乙酰酶抑制剂并监测生物标志物的方法
CN102548975A (zh) *	2009-07-07	2012-07-04	安瑟生物科技私人有限公司	组蛋白去乙酰化酶抑制剂
CN102775368A (zh) *	2011-05-10	2012-11-14	中国科学院上海药物研究所	一类噻唑类化合物及其制备方法和用途
CN102775368B (zh) *	2011-05-10	2016-08-17	上海驺虞医药科技有限公司	一类噻唑类化合物及其制备方法和用途
CN103917231A (zh) *	2011-09-13	2014-07-09	药品循环公司	组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
CN103917231B (zh) *	2011-09-13	2016-09-28	药品循环有限责任公司	组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
CN103906732A (zh) *	2011-10-28	2014-07-02	株式会社钟根堂	用作hdac抑制剂的异羟肟酸酯衍生物以及包含所述衍生物的药物组合物
CN119528810A (zh) *	2024-12-09	2025-02-28	山东第一医科大学(山东省医学科学院)	喹啉类化合物及其应用

Also Published As

Publication number	Publication date
ZA200507751B (en)	2007-01-31
UA82876C2 (en)	2008-05-26

Publication	Publication Date	Title
CN1795175A (zh)	2006-06-28	作为组蛋白脱乙酰基酶抑制剂的乙炔衍生物
JP4243628B2 (ja)	2009-03-25	治療剤としてのヒドロキサメート
US20060058553A1 (en)	2006-03-16	Novel bicyclic hydroxamates as inhibitors of histone deacetylase
HUE035654T2 (en)	2018-05-28	6-o-substituted benzoxazole and benzothiazole compounds and methods for inhibiting CSF-1R signaling
CN1296354C (zh)	2007-01-24	具有药物活性的吡咯烷衍生物
US7368476B2 (en)	2008-05-06	Hydroxamates as therapeutic agents
CN1826317A (zh)	2006-08-30	酪氨酸激酶抑制剂
US20050124614A1 (en)	2005-06-09	3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis
US8324389B2 (en)	2012-12-04	Solid forms of a Raf kinase inhibitor
CN1768031A (zh)	2006-05-03	作为治疗剂的异羟肟酸酯
HK1169102B (en)	2016-10-21	Hydroxamates as therapeutic agents
US20070105939A1 (en)	2007-05-10	Mesylate salt of 5-(2-dimethylaminoethoxy)-1H-indole-2-carboxylic acid [3-(4-hydroxycarbamoylphenyl)prop-2-ynyl]amide

Legal Events

Date	Code	Title	Description
2006-05-03	C06	Publication
2006-05-03	PB01	Publication
2006-06-28	C10	Entry into substantive examination
2006-06-28	SE01	Entry into force of request for substantive examination
2012-03-21	C12	Rejection of a patent application after its publication
2012-03-21	RJ01	Rejection of invention patent application after publication	Open date: 20060503